Quality in Hemostasis and Thrombosis—Part I

Emmanuel J. Favaloro; Mario Plebani; Giuseppe Lippi

doi:10.1055/s-0032-1321955

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2012; 38(06): 549-552
DOI: 10.1055/s-0032-1321955

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Quality in Hemostasis and Thrombosis—Part I

Emmanuel J. Favaloro

¹Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia

,

Mario Plebani

²Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy

,

Giuseppe Lippi

³Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Bonar R, Favaloro EJ, Adcock D. Quality in coagulation and haemostasis testing. Biochem Med 2010; 20 (2) 184-199
2 Plebani M, Favaloro EJ, Lippi G. Patient safety and quality in laboratory and hemostasis testing: a renewed loop?. Semin Thromb Hemost 2012; 38 (6) 553-558
3 Plebani M, Lippi G. Closing the brain-to-brain loop in laboratory testing. Clin Chem Lab Med 2011; 49 (7) 1131-1133
4 Lippi G, Chance JJ, Church S , et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011; 49 (7) 1113-1126
5 Favaloro EJ, Lippi G. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?. Clin Chem Lab Med 2010; 48 (3) 309-321
6 Plebani M, Lippi G. Improving the post-analytical phase. Clin Chem Lab Med 2010; 48 (4) 435-436
7 Olson JD, Harrison CR. Event management: the heart of the quality program. Semin Thromb Hemost 2012; 38 (6) 559-564
8 Cooper G, DeJonge N, Ehrmeyer S , et al. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality. Clin Chem Lab Med 2011; 49 (5) 793-802
9 Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost 2012; 38 (6) 565-575
10 Carraro P, Zago T, Plebani M. Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors. Clin Chem 2012; 58 (3) 638-642
11 Favaloro EJ, Adcock-Funk DM, Lippi G. Preanalytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab Med 2012; 43: 1-10
12 Favaloro EJ. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry. Clin Chem Lab Med 2011; 49 (4) 737-739
13 Favaloro EJ, Lippi G, Raijmakers MT, Vader HL, van der Graaf F. Discard tubes are sometimes necessary when drawing samples for hemostasis. Am J Clin Pathol 2010; 134 (5) 851
14 Adcock-Funk DM, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation and storage in hemostasis testing. Semin Thromb Hemost 2012; 38 (6) 576-585
15 Lippi G, Salvagno GL, Adcock DM, Gelati M, Guidi GC, Favaloro EJ. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample. Int J Lab Hematol 2010; 32 (1 Pt 2) 132-138
16 Tripodi A. Problems and solutions for testing hemostasis assays while patients are on anticoagulants. Semin Thromb Hemost 2012; 38 (6) 586-592
17 Tripodi A, Di Iorio D, Lippi G, Testa S, Manotti C. Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus Document of FCSA, SIMeL, SIBioC and CISMEL. Clin Chem Lab Med DOI: 10.1515/cclm-2012-0327
18 Favaloro EJ, Lippi G. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?. Clin Chem Lab Med 2011; 49 (5) 755-757
19 Harenberg J, Giese C, Marx S, Krämer R. Determination of dabigatran in human plasma samples. Semin Thromb Hemost 2012; 38 (1) 16-22
20 Harenberg J, Erdle S, Marx S, Krämer R. Determination of rivaroxaban in human plasma samples. Semin Thromb Hemost 2012; 38 (2) 178-184
21 Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis. Semin Thromb Hemost 2012; 38 (1) 23-30
22 Bidlingmaier C, Kenet G, Kurnik K , et al. Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies. Semin Thromb Hemost 2011; 37 (7) 814-825
23 Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology 2011; 43 (7) 682-692
24 Cuker A. Unfractionated heparin for the treatment of venous thromboembolism: best practices and areas of uncertainty. Semin Thromb Hemost 2012; 38 (6) 593-599
25 Tufano A, Coppola A, Cerbone AM, Ruosi C, Franchini M. Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost 2011; 37 (3) 252-266
26 Cooper PC, Goodeve AC, Beauchamp NJ. Quality in molecular biology testing for inherited thrombophilia disorders. Semin Thromb Hemost 2012; 38 (6) 600-612
27 Favaloro EJ, Mohammed S, Pati N, Ho MY, McDonald D. A clinical audit of congenital thrombophilia investigation in tertiary practice. Pathology 2011; 43 (3) 266-272
28 Favaloro EJ. Assessment for antithrombin deficiency in the real world. Int J Lab Hematol 2011; 33 (6) 656-658 , author reply 659–660
29 Favaloro EJ, Reben R, Mohammed S, Koutts J. Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations. Intern Med J 2012; 42 (4) 427-434
30 Lippi G, Favaloro EJ, Plebani M. Direct-to-consumer testing: more risks than opportunities. Int J Clin Pract 2011; 65 (12) 1221-1229
31 Dardikh M, Meijer P, van der Meer F, Favaloro EJ, Verbruggen B. Acquired functional coagulation inhibitors: review on epidemiology, results of a wet-workshop on laboratory detection, and implications for quality of inhibitor diagnosis. Semin Thromb Hemost 2012; 38 (6) 613-621
32 Kershaw G, Favaloro EJ. Laboratory identification of factor inhibitors: an update. Pathology 2012; 44 (4) 293-302
33 Hayward CPM, Moffat KA, Plumhoff E , et al. External quality assessment of platelet disorder investigations: results of international surveys on diagnostic tests for dense granule deficiency and platelet aggregometry interpretation. Semin Thromb Hemost 2012; 38 (6) 622-631
34 Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010; 48 (5) 579-598
35 Favaloro EJ. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost 2009; 35 (2) 139-149
36 Favaloro EJ, Bonar R. Proficiency testing/external quality assurance for the PFA-100. Clin Chem Lab Med 2012; 50: 1393-1401
37 Bonar RA, Favaloro EJ, Marsden K. External Quality Assurance for Heparin Monitoring. Semin Thromb Hemost 2012; 38 (6) 632-640